Abstract
Recent studies have demonstrated that tumor necrosis factor-α(TNF-α) selectively decreases production of collagens I and III, the major types of collagen in the dermis, and increases production of collagenase in cultured dermal fibroblasts. The effects of TNF-α on collagens I, III and VI, fibronectin and collagenase gene expression by fibroblasts derived from normal individuals and patients with systemic sclerosis (SSc) were studied. SSc is characterized by excessive accumulation of collagen in the skin and in certain organs. TNF-α inhibited collagen production and mRNA levels of collagens I and III and of fibronectin, and stimulated collagenase activity and collagenase mRNA levels in SSs fibroblasts. Levels of mRNA for α1(VI) and α3(VI) collagen and for Β-actin were unaltered in SSc fibroblasts incubated with TNF-α. Similar results were observed for mRNA levels in normal fibroblasts incubated with TNF-α. These results suggest that TNF-α could be expected to be beneficial in the treatment of SSc. In addition, our results indicated that collagen-VI expression is regulated independently from expression of collagens I and III, and expression of fibronectin and collagens I and III are regulated in parallel in fibroblasts treated with TNF-α.
Similar content being viewed by others
References
Angel P, Poting A, Mallick U, Rahmsdorf HJ, Schorpp M, Herrlich P (1986) Induction of metallothionein and other mRNA species by carcinogens and tumor promoters in primary human skin fibroblasts. Mol Cell Biol 6: 1760–1766
Arakawa M, Hatamochi A, Takeda K, Ueki H (1990) Increased collagen synthesis accompanying elevated m-RNA levels in cultured Werner's syndrome fibroblasts. J Invest Dermatol 94: 187–190
Berman B, Duncan MR (1990) Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin. Br J Dermatol 123: 339–346
Bernard MP, Kolbe M, Weil D, Chu M-L (1985) Human cellular fibronectin: Comparison of the carboxyl-terminal portion with rat identifies primary structural domains separated by hypervariable regions. Biochemistry 24: 2698–2704
Beutler B, Cerami A (1987) Cachectin: More than a tumor necrosis factor. N Engl J Med 316: 379–385
Chu M-L, Myers JC, Bernard MP, Ding JF, Ramirez F (1982) Cloning and characterization of five overlapping cDNAs specific for the human proα1(I) collagen chain. Nucleic Acids Res 10: 5925–5934
Chu M-L, Mann K, Deutzmann R, Pribula-Conway D, Hsu-Chen C-C, Bernard MP, Timpl R (1987) Characterization of three constituent chains of collagen type VI by peptide sequences and cDNA clones. Eur J Biochem 168: 309–317
Czaja MJ, Weiner FR, Eghbali M, Giambrone M-A, Eghbali M, Zern MA (1987) Differential effects of γ-interferon on collagen and fibronectin gene expression. J Biol Chem 262: 13348–13351
Dayer JM, Beutler B, Cerami A (1985) Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. Exp Med 162: 2163–2168
Diegelmann RF, Peterkofsky B (1972) Collagen biosynthesis during connective tissue development in chick embryo. Dev Biol 28: 443–453
Duncan MR, Berman B (1987) Persistence of a reduced-collagen-producing phenotype in cultured scleroderma fibroblasts after short-term exposure to interferons. J Clin Invest 79: 1318–1324
Fleischmajer R (1977) The pathophysiology of scleroderma. Int J Dermatol 16: 310–318
Gunning P, Ponte P, Okayama H, Engel J, Blau H, Kedes L (1983) Isolation and characterization of full-length cDNA clones for human α-, Β-, and γ-actin mRNA: Skeletal but not cytoplasmic actins have an amino-terminal cystein that is subsequently removed. Mol Cell Biol 3: 787–795
Hatamochi A, Aumailley M, Mauch C, Chu M-L, Timpl R, Krieg T (1989) Regulation of collagen VI expression in fibroblasts; Effects of cell density, cell-matrix interactions, and chemical transformation. J Biol Chem 264: 3494–3499
Hatamochi A, Takeda K, Arakawa M, Ono M, Ueki H (1991) Collagen metabolism in scleroderma fibroblasts. Curr Top Scleroderma, Tokyo
Heckmann M, Aumailley M, Hatamochi A, Chu M-L, Timpl R, Krieg TG (1989) Down-regulation of α3 (VI) chain expression by γ-interferon decreases synthesis and deposition of collagen type VI. Eur J Biochem 182: 719–726
Hein R, Behr J, Hündgen M, Hunzelmann N, Meurer M, Braun-Falco O, Urbanski A, Krieg T (1992) Treatment of systemic sclerosis with γ-interferon. Br J Dermatol 126: 496–501
Ignotz RA, Massague J (1986) Transforming growth factor-Β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261: 4337–4345
Jimenez SA, Freundlich B, Rosenbloom J (1984) Selective inhibition of diploid fibroblast collagen synthesis by interferons. J Clin Invest 74: 1112–1116
KÄhÄri V-M, Heino J, Vuorio T, Vuorio E (1988) Interferon-α and interferon-γ reduce excessive collagen synthesis and pro-collagen mRNA levels of scleroderma fibroblasts in culture. Biochim Biophys Acta 968: 45–50
Krieg T, Luderschmidt C, Weber L, Muller PK, Braun-Falco O (1981) Scleroderma fibroblasts: some aspects of in vitro assessment of collagen synthesis. Arch Dermatol Res 270: 263–272
LeRoy EC (1974) Increased collagen synthesis by scleroderma skin fibroblasts in vitro. J Clin Invest 54: 880–889
Mauviel A, Heino J, KÄhÄri V-M, Hartmann D-J, Loyau G, Pujiol J-P, Vuorio E (1991) Comparative effects of interleukin-1 and tumor necrosis factor-α on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts. J Invest Dermatol 96: 243–249
Miskulin M, Dalgleish R, Kluve-Becherman B, Rennard SI, Tolstoshev P, Brantly M, Crystal RG (1986) Human type III collagen gene expression is coordinately modulated with the type I collagen genes during fibroblast growth. Biochemistry 25: 1408–1413
Ohta A, Uitto J (1987) Procollagen gene expression by scleroderma fibroblasts in culture: Inhibition of collagen production and reduction of proα1(I) and proα1(III) collagen messenger RNA steady-state levels by retinoids. Arthritis Rheum 30; 404–411
Peltonen J, KÄhÄri L, Uitto J, Jimenez SA (1990) Increased expression of type VI collagen genes in systemic sclerosis. Arthritis Rheum 33: 1829–1835
Rosenbloom J, Feldman G, Freundlich B, Jimenez SA (1986) Inhibition of excessive scleroderma fibroblast collagen synthesis by recombinant gamma interferon. Arthritis Rheum 29: 851–856
Scharffetter K, Heckmann M, Hatamochi A, Mauch C, Stein B, Riethmüller G, Ziegler-Heitbrock H-WL, Krieg T (1989) Synergistic effect of tumor necrosis factor-α and interferon-γ on collagen synthesis of human skin fibroblasts in vitro. Exp Cell Res 181: 409–419
Solis-Herruzo JA, Brenner DA, Chojkier M (1988) Tumor necrosis factor α inhibits collagen gene transcription and collagen synthesis in cultured human fibroblasts. J Biol Chem 263: 5841–5845
Subcommittee for Slceroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23: 581–590
Uitto J, Bauer EA, Eisen AZ (1979) Scleroderma. Increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts. J Clin Invest 64: 921–930
Varga J, Rosenbloom J, Jimenez SA (1987) Transforming growth factor Β (TGFΒ) caused a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J 247: 597–604
Winkelmann RK (1976) Pathogenesis and staging of scleroderma. Acta Derm Venereol (Stockh) 56: 83–92
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takeda, K., Hatamochi, A., Arakawa, M. et al. Effects of tumor necrosis factor-α on connective tissue metabolism in normal and scleroderma fibroblast cultures. Arch Dermatol Res 284, 440–444 (1993). https://doi.org/10.1007/BF00373353
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00373353